Novartis Ag (NVSEF) Cash from Discontinued Operations (2013 - 2023)

Novartis Ag has disclosed Cash from Discontinued Operations across 7 years of filings, most recently posting 164000000.0 for Q4 2023.

• Cash from Discontinued Operations for Q4 2023 came in at 164000000.0, down 52.19% year-over-year; the trailing twelve-month figure through Dec 2023 was 402000000.0 (down 49.05% YoY), and the FY2023 annual result was 238000000.0, down 80.12% from the prior year.
• Cash from Discontinued Operations came in at 164000000.0 for Q4 2023 at Novartis Ag, up from 74000000.0 in the prior quarter.
• In the past five years, Cash from Discontinued Operations ranged from a high of 499000000.0 in Q2 2019 to a low of 59000000.0 in Q2 2023.
• The 3-year median for Cash from Discontinued Operations is 134500000.0 (2023), against an average of 221000000.0.
• Across the five-year window, Cash from Discontinued Operations rose 16.05% in 2019 and tumbled 83.41% in 2023, its largest moves.
• Novartis Ag's Cash from Discontinued Operations stood at 499000000.0 in 2019, then tumbled by 31.26% to 343000000.0 in 2022, then plunged by 52.19% to 164000000.0 in 2023.
• The last three Cash from Discontinued Operations figures came in at 164000000.0 (Q4 2023), 74000000.0 (Q3 2023), and 59000000.0 (Q2 2023), per Business Quant data.